A decision by Canada’s Drug Agency will make it more difficult for Canadians to access a drug shown to slow Alzheimer’s disease in some people, says an Ottawa cognitive neurologist and researcher. Dr.
European drug regulators are endorsing a new and simpler treatment for sleeping sickness, in what could be a giant boost to efforts to eliminate the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results